Tyra Biosciences Price Target Cut to 30.00 by Analysts at HC Wainwright
TYRA Stock | USD 16.00 0.28 1.78% |
About 64% of all Tyra Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that some traders are interested. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
Tyra |
Tyra Biosciences had its price objective decreased by research analysts at HC Wainwright from 32.00 to 30.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwrights price target indicates a potential upside of 86.68 percent from
Read at thelincolnianonline.com
Tyra Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Tyra Biosciences Fundamental Analysis
We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Tyra Biosciences is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Tyra Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.
Peers
Tyra Biosciences Related Equities
IPSC | Century Therapeutics | 20.74 | ||||
RAPT | RAPT Therapeutics | 9.82 | ||||
CCCC | C4 Therapeutics | 8.59 | ||||
CNTB | Connect Biopharma | 6.19 | ||||
GLUE | Monte Rosa | 5.93 | ||||
ERAS | Erasca | 5.04 | ||||
MLYS | Mineralys Therapeutics, | 4.71 | ||||
MOLN | Molecular Partners | 3.19 | ||||
CGEM | Cullinan Oncology | 2.51 | ||||
XLO | Xilio Development | 2.02 | ||||
STOK | Stoke Therapeutics | 1.19 | ||||
PMVP | Pmv Pharmaceuticals | 0.63 | ||||
HOWL | Werewolf Therapeutics | 0.51 | ||||
EWTX | Edgewise Therapeutics | 0.31 | ||||
IKNA | Ikena Oncology | 1.17 | ||||
DSGN | Design Therapeutics | 2.93 | ||||
PHVS | Pharvaris | 7.49 |
Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world |